Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kronos Bio, Inc.

0.7144
-0.1784-19.98%
Post-market: 0.7001-0.0143-2.00%19:53 EDT
Volume:9.00M
Turnover:6.26M
Market Cap:43.56M
PE:-0.50
High:0.7400
Open:0.7287
Low:0.6700
Close:0.8928
Loading ...

Kronos Bio provides update on review of strategic alternatives

TIPRANKS
·
15 Nov 2024

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024

GlobeNewswire
·
15 Nov 2024

Piper Sandler Downgrades Kronos Bio to Neutral From Overweight, Adjusts Price Target to $1 From $6

MT Newswires Live
·
14 Nov 2024

TD Cowen Downgrades Kronos Bio to Hold From Buy

MT Newswires Live
·
14 Nov 2024

Kronos Bio Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
14 Nov 2024

Kronos Bio Cut to Hold From Buy by TD Cowen

Dow Jones
·
14 Nov 2024

Piper downgrades Kronos Bio on istisociclib discontinuation

TIPRANKS
·
14 Nov 2024

Kronos Bio downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
14 Nov 2024

Kronos Bio Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $1 From $6

THOMSON REUTERS
·
14 Nov 2024

Kronos Bio Inc : TD Cowen Cuts to Hold From Buy

THOMSON REUTERS
·
14 Nov 2024

Kronos Bio Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

TD Cowen downgrades Kronos Bio (KRON) to a Hold

TIPRANKS
·
14 Nov 2024

Kronos Bio downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
14 Nov 2024

Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
14 Nov 2024

Kronos Bio Q3 2024 GAAP EPS $(0.23) Beats $(0.26) Estimate, Sales $2.37M Beat $2.10M Estimate

Benzinga
·
14 Nov 2024

BRIEF-Kronos Bio Q3 EPS USD -0.23

Reuters
·
14 Nov 2024

Kronos Bio Inc - to Evaluate Strategic Alternatives

THOMSON REUTERS
·
14 Nov 2024

Kronos Bio Q3 Cash & Investments USD 124.9 Million

THOMSON REUTERS
·
14 Nov 2024

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives

GlobeNewswire
·
14 Nov 2024

Kronos Bio's Market Cap Drops To US$50m Leaving Insiders With Losses

Simply Wall St.
·
10 Nov 2024